Of the 271 patients who received romiplostim in ITP clinical studies, 55 (20%) were age 65 and over, and 27 (10%) were 75 and over.
Kliinisissä tutkimuksissa romiplostiimia saaneista 271: stä ITP- potilaasta 55 (20%) oli yli 65- vuotiaita ja 27 (10%) yli 75- vuotiaita.